11/12
03:55 pm
ntla
Form SCHEDULE 13G Intellia Therapeutics, Filed by: GOLDMAN SACHS GROUP INC
Low
Report
Form SCHEDULE 13G Intellia Therapeutics, Filed by: GOLDMAN SACHS GROUP INC
11/12
01:48 pm
ntla
Form SCHEDULE 13G Intellia Therapeutics, Filed by: Contrarius Investment Management Ltd
Low
Report
Form SCHEDULE 13G Intellia Therapeutics, Filed by: Contrarius Investment Management Ltd
11/10
05:25 pm
ntla
Form 8-K Intellia Therapeutics, For: Nov 08
Low
Report
Form 8-K Intellia Therapeutics, For: Nov 08
11/6
04:28 pm
ntla
Form 10-Q Intellia Therapeutics, For: Sep 30
High
Report
Form 10-Q Intellia Therapeutics, For: Sep 30
11/6
04:09 pm
ntla
Form 8-K Intellia Therapeutics, For: Nov 06
High
Report
Form 8-K Intellia Therapeutics, For: Nov 06
11/4
04:50 pm
ntla
Form SCHEDULE 13G/A Intellia Therapeutics, Filed by: ARK Investment Management LLC
High
Report
Form SCHEDULE 13G/A Intellia Therapeutics, Filed by: ARK Investment Management LLC
10/29
04:23 pm
ntla
Form 8-K Intellia Therapeutics, For: Oct 29
Medium
Report
Form 8-K Intellia Therapeutics, For: Oct 29
10/3
05:14 pm
ntla
Form 4 Intellia Therapeutics, For: Oct 01 Filed by: Schultes Birgit C
Low
Report
Form 4 Intellia Therapeutics, For: Oct 01 Filed by: Schultes Birgit C
10/3
05:13 pm
ntla
Form 4 Intellia Therapeutics, For: Oct 01 Filed by: Dube Michael P
Low
Report
Form 4 Intellia Therapeutics, For: Oct 01 Filed by: Dube Michael P
9/25
04:19 pm
ntla
Form 8-K Intellia Therapeutics, For: Sep 25
Low
Report
Form 8-K Intellia Therapeutics, For: Sep 25